Highlights Medicover January – March 2005

- Revenue for the first quarter ending 31 March 2005 amounted to € 13.2 million (€ 9.7 million), representing 36 percent revenue growth versus last year. Excluding the acquisition effect, the revenue growth was 33 percent. - Constant currency revenue growth amounted to 21 percent and excluding acquisitions, 19 percent. - Membership growth was robust with 11,700 (5,000) new members for the quarter, bringing total members to 151,600 (122,000). - The operating profit before depreciation and amortization (EBITDA) for the quarter amounted to € 1.1 million (€ 0.6 million) or 8.6 percent (6.5 percent) of revenue. - The operating profit (EBIT) for the quarter amounted to € 0.3 million (loss € 0.2 million). - The profit after tax for the quarter amounted to € 36,000 (loss € 0.2 million), equivalent to a profit per share of € 0.003 (loss € 0.014) and the diluted profit per share was € 0.003 (loss € 0.014). - Net cash inflow from operating activities after tax payments was € 0.3 million (outflow € 0.1 million) for the quarter. - In April, we announced an additional acquisition in the Polish laboratory market and a proposed rights issue of about SEK 107 million to finance further strong expansion. Investor Relations Contacts Fredrik Rågmark Managing Director Phone: +32 2 357 55 77 E-mail: fredrik.ragmark@medicover.com Joe Ryan Financial Director Phone: +32 2 357 55 77 E-mail: joe.ryan@medicover.com